EP2471917A4 - Polynucléotide issu d'une nouvelle souche de virus de l'hépatite c et son utilisation - Google Patents
Polynucléotide issu d'une nouvelle souche de virus de l'hépatite c et son utilisationInfo
- Publication number
- EP2471917A4 EP2471917A4 EP10811924A EP10811924A EP2471917A4 EP 2471917 A4 EP2471917 A4 EP 2471917A4 EP 10811924 A EP10811924 A EP 10811924A EP 10811924 A EP10811924 A EP 10811924A EP 2471917 A4 EP2471917 A4 EP 2471917A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- polynucleotide
- seq
- amino acid
- virus strain
- new hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 241000711549 Hepacivirus C Species 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 5
- 235000001014 amino acid Nutrition 0.000 abstract 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 235000013922 glutamic acid Nutrition 0.000 abstract 2
- 239000004220 glutamic acid Substances 0.000 abstract 2
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 abstract 2
- 239000004471 Glycine Substances 0.000 abstract 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 235000004279 alanine Nutrition 0.000 abstract 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24241—Use of virus, viral particle or viral elements as a vector
- C12N2770/24243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24251—Methods of production or purification of viral material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009197923 | 2009-08-28 | ||
| PCT/JP2010/064417 WO2011024875A1 (fr) | 2009-08-28 | 2010-08-25 | Polynucléotide issu d'une nouvelle souche de virus de l'hépatite c et son utilisation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2471917A1 EP2471917A1 (fr) | 2012-07-04 |
| EP2471917A4 true EP2471917A4 (fr) | 2013-03-13 |
Family
ID=43627975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP10811924A Withdrawn EP2471917A4 (fr) | 2009-08-28 | 2010-08-25 | Polynucléotide issu d'une nouvelle souche de virus de l'hépatite c et son utilisation |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US8609403B2 (fr) |
| EP (1) | EP2471917A4 (fr) |
| JP (1) | JPWO2011024875A1 (fr) |
| CA (1) | CA2769879C (fr) |
| WO (1) | WO2011024875A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105164251A (zh) * | 2012-09-28 | 2015-12-16 | 国立大学法人神户大学 | C型肝炎病毒颗粒形成促进剂和c型肝炎病毒颗粒的产生方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0627000B1 (fr) | 1992-01-31 | 2003-10-29 | Abbott Laboratories | Systemes d'expression mammiferes generant des proteines du vhc |
| US6127116A (en) * | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
| DE19915178A1 (de) | 1999-04-03 | 2000-10-05 | Univ Mainz Johannes Gutenberg | Hepatitis C Virus Zellkultursystem |
| EP1327687A4 (fr) | 2000-10-03 | 2004-08-11 | Tokyo Metropolitan Org Med Res | Procedes d'infection par le virus de l'hepatite c |
| JP4880116B2 (ja) | 2000-12-01 | 2012-02-22 | 財団法人 東京都医学総合研究所 | 劇症c型肝炎ウイルス株の遺伝子 |
| WO2002059321A2 (fr) * | 2001-01-23 | 2002-08-01 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Réplicons du virus de l'hépatite c et cellules renforcées pour des réplicons |
| EP1454524A4 (fr) | 2001-10-30 | 2004-12-08 | Tokyo Metropolitan Org Med Res | Animal transgenique a gene hcv |
| EP1666598B1 (fr) | 2003-09-19 | 2015-08-12 | Tokyo Metropolitan Institute of Medical Science | Acide nucleique et gene provenant d'une nouvelle souche vhc et cellule a replication autonome comprenant ce gene |
-
2010
- 2010-08-25 US US13/388,382 patent/US8609403B2/en not_active Expired - Fee Related
- 2010-08-25 JP JP2010536671A patent/JPWO2011024875A1/ja not_active Ceased
- 2010-08-25 CA CA2769879A patent/CA2769879C/fr not_active Expired - Fee Related
- 2010-08-25 WO PCT/JP2010/064417 patent/WO2011024875A1/fr not_active Ceased
- 2010-08-25 EP EP10811924A patent/EP2471917A4/fr not_active Withdrawn
-
2013
- 2013-11-13 US US14/078,903 patent/US20140178856A1/en not_active Abandoned
Non-Patent Citations (3)
| Title |
|---|
| DATABASE UniProt [online] 2 September 2008 (2008-09-02), "Hepatitis C virus subtype 1a", XP002690171, Database accession no. B3TKG0_9HEPC * |
| DATABASE UniProt [online] 2 September 2008 (2008-09-02), "Hepatitis C virus subtype 1a", XP002690172, Database accession no. B3TKQ1_9HEPC * |
| See also references of WO2011024875A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2769879A1 (fr) | 2011-03-03 |
| US20140178856A1 (en) | 2014-06-26 |
| EP2471917A1 (fr) | 2012-07-04 |
| WO2011024875A1 (fr) | 2011-03-03 |
| JPWO2011024875A1 (ja) | 2013-01-31 |
| US20120204279A1 (en) | 2012-08-09 |
| CA2769879C (fr) | 2015-06-09 |
| US8609403B2 (en) | 2013-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201401211A1 (ru) | Улучшенные варианты фермента химозина | |
| EA201000327A1 (ru) | Белок | |
| EA201170878A1 (ru) | Полипептиды с ксиланазной активностью | |
| NZ591855A (en) | Novel immunotherapy against several tumors including neuronal and brain tumors | |
| EA200901430A1 (ru) | Варианты фермента аспарагиназы и их применение | |
| UA124343C2 (uk) | Капсиди аденоасоційованого вірусу і спосіб його використання | |
| MY187542A (en) | Carbohydrate degrading polypeptide and uses thereof | |
| NZ628446A (en) | Fibronectin based scaffold domain proteins that bind to myostatin | |
| MA31997B1 (fr) | Nouveaux derives de l'insuline presentant un profil d'action extremement retarde | |
| MX345513B (es) | Polipeptidos variantes de exoamilasa. | |
| EA201001881A1 (ru) | Пролинспецифичная протеаза из penicillium chrysogenum | |
| MX369328B (es) | Detergente para vajilla solido con accion mejorada de la proteasa. | |
| NZ629843A (en) | Identification of channelrhodopsin-2 (chop2) mutations and methods of use | |
| MX2015003310A (es) | Moleculas de union il-17a novedosas y usos medicos de las mismas. | |
| EP2589658A4 (fr) | Polypeptide de région partielle de la protéine reic/dkk-3 | |
| WO2009024327A3 (fr) | Nouvelles protéines pour une utilisation dans des infections par staphylococcus chez des êtres humains et des animaux | |
| NZ706884A (en) | Fc gamma receptor iib variants | |
| MX2020011083A (es) | Proteina. | |
| EA201300056A1 (ru) | Полипептид с активностью ацетилксиланэстеразы и его применения | |
| MX2016006277A (es) | Secuencia de endolisina kz144 modificada. | |
| NZ703514A (en) | Fviii peptides for immune tolerance induction and immunodiagnostics | |
| RU2014144881A (ru) | Способ экспрессии полипептидов с применением модифицированных нуклеиновых кислот | |
| HRP20201945T1 (hr) | Postupak proizvodnje gonadotropina | |
| WO2008105178A1 (fr) | Agent utilisé pour améliorer la résistance d'un liposome contre un constituant biologique et liposome modifié avec ledit agent | |
| CY1111630T1 (el) | Παραγωγα κυτοκινων |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20120319 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A01K 67/027 20060101ALI20130122BHEP Ipc: C12N 15/09 20060101AFI20130122BHEP Ipc: G01N 33/50 20060101ALI20130122BHEP Ipc: C12N 1/19 20060101ALI20130122BHEP Ipc: G01N 33/15 20060101ALI20130122BHEP Ipc: C12N 7/00 20060101ALI20130122BHEP Ipc: C12N 1/15 20060101ALI20130122BHEP Ipc: C12N 1/21 20060101ALI20130122BHEP Ipc: C12Q 1/02 20060101ALI20130122BHEP Ipc: C12N 5/10 20060101ALI20130122BHEP |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20130208 |
|
| 17Q | First examination report despatched |
Effective date: 20140328 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| INTG | Intention to grant announced |
Effective date: 20150504 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Effective date: 20150814 |